Drugs studied at the Mays Cancer Center help those with bone marrow cancers

Ruben Mesa, MD, FACP executive director of the Mays Cancer Center at UT Health San Antonio, has seen too many patients and families struggle with deadly bone marrow cancers. He is an international expert on myeloproliferative neoplasms (MPNs), a group of bone marrow disorders that often lead to leukemia.

A 25-year trailblazer in MPN research, he led the development of the first U.S. guidelines on diagnosis and treatment of these disorders. He has been principal investigator or co-principal investigator…

Previous Getting loan ready with the TSBDC
Next VyStar membership increases at a slower-than-typical pace in second quarter

No Comment

Leave a reply

Your email address will not be published.